World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
59
Citations
16455
World Ranking
12350
National Ranking
953

Mary Frances McMullin publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Mary Frances McMullin sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 371 publications — 87th percentile

87% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Mary Frances McMullin D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Mary Frances McMullin sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 59 D-Index — 38th percentile

38% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Mary Frances McMullin is affiliated with Queen's University Belfast in the United Kingdom. Their research spans multiple disciplines within medicine, with particular focus on hematology, genetics, and molecular biology.

The main fields of study for McMullin include Medicine and Biochemistry, Genetics and Molecular Biology. Within these areas, their work extends into specialized subfields such as Genetics, Hematology, Molecular Biology, Rheumatology, and Immunology.

Their research topics cover several key areas related to blood disorders and treatments. The primary topics include:

  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Acute Myeloid Leukemia Research
  • Kruppel-like factors research
  • Chronic Myeloid Leukemia Treatments
  • Eosinophilic Disorders and Syndromes
  • Hemoglobinopathies and Related Disorders
  • Acute Lymphoblastic Leukemia research

McMullin has contributed to multiple papers across prominent journals. Notable recent publications are:

  • "Protein tyrosine phosphatase receptor type C (PTPRC or CD45)", 2021, Journal of Clinical Pathology
  • "Ruxolitinib Versus Best Available Therapy for Polycythemia Vera Intolerant or Resistant to Hydroxycarbamide in a Randomized Trial", 2023, Journal of Clinical Oncology
  • "Molecular pathogenesis of the myeloproliferative neoplasms", 2021, Journal of Hematology & Oncology
  • "Significance of NPM1 Gene Mutations in AML", 2021, International Journal of Molecular Sciences
  • "FLT3 inhibitors as MRD-guided salvage treatment for molecular failure in FLT3 mutated AML", 2023, Leukemia

The most frequent venues for McMullin's publications include:

  • Blood
  • British Journal of Haematology
  • Journal of Clinical Oncology
  • Leukemia
  • Irish Journal of Medical Science (1971 -)

Frequent collaborators in McMullin's work are:

  • Claire Harrison
  • Adam J. Mead
  • Ruben A. Mesa
  • Steven Knapper
  • Vikas Gupta

Best Publications

  • JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis.

    Linda M. Scott;Wei Tong;Ross L. Levine;Mike A. Scott

  • Philadelphia-Negative Classical Myeloproliferative Neoplasms: Critical Concepts and Management Recommendations From European LeukemiaNet

    Tiziano Barbui;Giovanni Barosi;Gunnar Birgegard;Francisco Cervantes

  • A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatment†‡

    Alan Kenneth Burnett;Donald Milligan;Archie G. Prentice;Anthony H. Goldstone

  • Classification and Personalized Prognosis in Myeloproliferative Neoplasms.

    Jacob Grinfeld;Jyoti Nangalia;E Joanna Baxter;David C Wedge

  • Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial.

    Alan K Burnett;Nigel H Russell;Robert Kerrin Hills;David Bowen

  • Guidelines for the diagnosis, investigation and management of polycythaemia/erythrocytosis

    Mary F. McMullin;D. Bareford;P. Campbell;A. R. Green

  • Factors influencing success of clinical genome sequencing across a broad spectrum of disorders

    Jenny C. Taylor;Jenny C. Taylor;Hilary C. Martin;Stefano Lise;John Broxholme

  • A gain-of-function mutation in the HIF2A gene in familial erythrocytosis

    Melanie J. Percy;Paul W. Furlow;Guy S. Lucas;Xiping Li

  • A family with erythrocytosis establishes a role for prolyl hydroxylase domain protein 2 in oxygen homeostasis

    Melanie J. Percy;Quan Zhao;Adrian Flores;Claire Harrison

  • Guideline for investigation and management of adults and children presenting with a thrombocytosis

    Claire N. Harrison;David Bareford;Nauman Butt;Peter Campbell

  • Two routes to leukemic transformation after a JAK2 mutation–positive myeloproliferative neoplasm

    Philip A. Beer;François Delhommeau;Jean-Pierre LeCouédic;Mark A. Dawson

  • Molecular and clinical features of the myeloproliferative neoplasm associated with JAK2 exon 12 mutations

    Francesco Passamonti;Chiara Elena;Susanne Schnittger;Radek C. Skoda

  • Attempts to optimize induction and consolidation treatment in acute myeloid leukemia: results of the MRC AML12 trial

    Alan Kenneth Burnett;Robert Kerrin Hills;Donald W. Milligan;Anthony H. Goldstone

  • How common are myeloproliferative neoplasms? A systematic review and meta-analysis

    Glen J Titmarsh;Andrew S Duncombe;Mary Frances McMullin;Michael O'Rorke

  • Mutation of von Hippel-Lindau tumour suppressor and human cardiopulmonary physiology.

    T G Smith;J T Brooks;G M Balanos;T R Lappin

  • Regulation of human metabolism by hypoxia-inducible factor

    Federico Formenti;Dumitru Constantin-Teodosiu;Yaso Emmanuel;Jane Cheeseman

  • The impact of dose escalation and resistance modulation in older patients with acute myeloid leukaemia and high risk myelodysplastic syndrome: the results of the LRF AML14 trial.

    Alan Kenneth Burnett;Donald Milligan;Anthony Goldstone;Archibald Prentice

  • A novel erythrocytosis-associated PHD2 mutation suggests the location of a HIF binding groove.

    Melanie J. Percy;Paul W. Furlow;Philip A. Beer;Terence R. J. Lappin

  • European Development of Clofarabine as Treatment for Older Patients With Acute Myeloid Leukemia Considered Unsuitable for Intensive Chemotherapy

    Alan K Burnett;Nigel Russell;W Jonathan Kell;Michael Dennis

  • Novel exon 12 mutations in the HIF2A gene associated with erythrocytosis.

    Melanie J. Percy;Philip A. Beer;Gavin Campbell;Ad W. Dekker

Frequent Co-Authors

Claire N. Harrison
Claire N. Harrison Guy's and St Thomas' NHS Foundation Trust
Ruben A. Mesa
Ruben A. Mesa The University of Texas Health Science Center at San Antonio
Alessandro M. Vannucchi
Alessandro M. Vannucchi University of Florence
Anthony R. Green
Anthony R. Green University of Cambridge
Robert Kerrin Hills
Robert Kerrin Hills University of Oxford
Alan Kenneth Burnett
Alan Kenneth Burnett University of Glasgow
Nigel H. Russell
Nigel H. Russell University of Nottingham
Frank S. Lee
Frank S. Lee University of Pennsylvania
Amylou C. Dueck
Amylou C. Dueck Mayo Clinic
Donald Milligan
Donald Milligan University of Birmingham

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Biology and Biochemistry in the USA opens doors to diverse, rewarding career paths. Students seeking flexible education options may also consider online degree programs in related fields. For those fascinated by human performance and body mechanics, a sports science degree online offers a comprehensive look into fitness, health, and rehabilitation, making it ideal for aspiring coaches or wellness professionals.

If you want to advance quickly, programs like an accelerated kinesiology degree online enable students to fast-track their expertise in movement science and exercise physiology. For those with a passion for healthcare, specialized certificate programs can lead to high-demand nursing roles. The shortest pmhnp program streamlines the path to psychiatric mental health nurse practitioner certification, while the 1 year post master's fnp online program helps current nurses swiftly qualify as family nurse practitioners.

Whether you’re interested in research, clinical practice, or sports health, these online and accelerated programs provide flexible routes to rewarding roles in the science and healthcare fields.

Best Scientists Citing Mary Frances McMullin

Trending Scientists